Due to the high heterogeneity and initially asymptomatic nature of breast cancer (BC), the
management of this disease depends on imaging together with immunohistochemical and …

Given their tumor-specific and stage-specific gene expression, long non-coding RNAs
(lncRNAs) have demonstrated to be potential molecular biomarkers for diagnosis …

Background Breast cancer (BC) is the most common malignancy in women, in whom it
reaches 20% of the total neoplasia incidence. Most BCs are considered sporadic and a …

Triple-negative breast cancer (TNBC) is one of the most aggressive subtypes of breast
cancer, marked by poor outcomes and dismal prognosis. Due to the absence of targetable …

Accumulating evidence suggests that genetic and epigenetic biomarkers hold potential for
enhancing the early detection and monitoring of breast cancer (BC). Epigenetic alterations …

Breast cancer is the most frequently diagnosed malignancy and the leading cause of cancer-
related death in women worldwide. Breast cancer development and progression are mainly …

Long intergenic non-coding RNA 01,087 (LINC01087) has been concerned as an oncogene
in breast cancer, while its mechanism in glioma has been little surveyed. Thus, we searched …

Background: Long non-coding RNA (LncRNA) is associated with disease progression. It is
reported that LINC01087 is highly expressed in cancer and participates in tumorigenesis …

Four datasets of TNBC were downloaded from TCGA and GEO databases. ImmPort
database was utilized to acquire immune-related mRNAs. Single sample gene set …

Triple-negative breast cancer (TNBC) is a malignant tumor that threatens women's health.
Exploring novel development-associated biomarkers could help improve the survival rate of …